ROCHE HOLDINGS AG SPN ADR EACH (RHHBY) Financials

RHHBY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 107.6 billion 68.0 billion
2023-06-30 93.8 billion 60.1 billion
2023-03-31 ? ?
2022-12-31 95.3 billion 65.1 billion

RHHBY Free Cash Flow and Stock based compensation

No data available :(

RHHBY Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 2.6 billion
2023-06-30 4.0 billion
2023-03-31 3.9 billion
2022-12-31 2.1 billion

RHHBY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - 1.9 billion
2023-06-30 - - -
2023-03-31 - - -
2022-12-31 10.6 billion 23.1 billion 1.3 billion

RHHBY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 948.1 million
2023-06-30 888.4 million
2023-03-31 ?
2022-12-31 864.4 million

RHHBY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-06-30 967.7 million - - -
2023-03-31 951.8 million - - -
2022-12-31 954.0 million - 7.0 billion -

RHHBY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 33.5 billion 9.7 billion

RHHBY

Price: $29.83

52 week price:
29.26
40.48

Dividend Yield: 0.31%

5-year range yield:
0.31%
4.36%

Forward Dividend Yield: 4.67%

Payout Ratio: 70.00%

Payout Ratio Range:
45.90%
77.00%

Dividend Per Share: 1.39 USD

Earnings Per Share: 1.99 USD

P/E Ratio: 16.02

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 1.5 million

Ebitda: 21.5 billion

Market Capitalization: 194.7 billion

Average Dividend Frequency: 1

Years Paying Dividends: 21

DGR3: 3.54%

DGR5: 3.79%

DGR10: 2.73%

Links: